EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials

Xu Zhang, Teng-Fei Wan, Jing Chen, Liang Liu

Aging · 2023

DOI: 10.18632/aging.205315 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Aging, 2023. Verfasst von Xu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, The General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, China. Hauptthemen laut MEDLINE: Stroke, Brain Ischemia, Ischemic Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenecteplase (TNK), a newer fibrinolytic agent with greater fibrin specificity and longer half-life than alteplase, may has practical advantages over alteplase in acute ischemic stroke (AIS) thrombolysis. We aimed to perform a systematic review and meta-analysis of randomized controlled trials (RCTs) to compare different doses of TNK (0.1, 0.25, 0.4 mg/kg) and alteplase in acute ischemic stroke patients. We systematically searched PubMed, Embase and https://clinicaltrials.gov/ for RCTs comparing TNK with alteplase in this population eligible for thrombolysis. The Cochrane Risk of Bias Tool was used to assess study quality. Random-effects or fixed-effects meta-analysis models were used for evaluating all outcomes. Total 10 RCTs with 5097 patients were included. Compared with alteplase, TNK at doses of 0.25 mg/kg may associated with the greatest odds to achieve 90-day excellent independence (mRS score ≤1), but there were no significant differences between other doses of TNK (0.1 mg/kg and 0.4 mg/kg) and alteplase. Among secondary outcomes, no significant differences were found in functional outcome (mRS score ≤2) and mortality at 90 days between any dose of TNK and alteplase. Compared with alteplase, TNK was effective at doses of 0.1 mg/kg and 0.25 mg/kg without increased risk of symptomatic intracerebral hemorrhage (sICH), but patients treated with TNK 0.4 mg/kg showed increased odds of sICH. In conclusion, compared with alteplase, intravenous thrombolysis with TNK at dose of 0.25 mg/kg has a better efficacy and similar safety profile and is a reasonable option for patients with AIS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeBrain IschemiaIschemic StrokeHumansTissue Plasminogen ActivatorTenecteplaseRandomized Controlled Trials as TopicCerebral HemorrhageTreatment Outcome

Stichwörter der Autor:innen

acute ischemic strokealteplaseintravenous thrombolysismeta-analysistenecteplase

Substanzen

Tissue Plasminogen ActivatorTenecteplase

Autor:innen und Institutionen

  • Department of Cardiac Surgery, The General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, China.
  • Department of Nursing, Xinqiao Hospital, Chongqing 400037, China.
  • Department of Critical Care Medicine, The General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, China.
  • Department of Neurology, Central Hospital of Baoji, Baoji, Shaanxi 721000, China.
  • Department of Neurology, The General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.

Zitieren

APA

Zhang, X., Wan, T. F., Chen, J., & Liu, L. (2023). Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Aging. https://doi.org/10.18632/aging.205315

Vancouver

Zhang X, Wan TF, Chen J, Liu L. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Aging. 2023. doi:10.18632/aging.205315

BibTeX
@article{Zhang2023,
  author = {Zhang, Xu and Wan, Teng-Fei and Chen, Jing and Liu, Liang},
  title = {Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205315}
}
Kostenlos starten →